skip to content

MR-HIFU research receives 3.6 Mio € Funding

We are happy to announce the start of the EU IHI project IMAGIO on interventional cancer therapies, which is coordinated by Philips Healthcare. Within this project, we received 3.6 Mio € funding for research on Magnetic Resonance-guided High Intensity Focused Ultrasound (MR-HIFU) for treatment of sarcomas.

We are excited that this project also allows us to bring the concept of temperature-responsive liposomal drug delivery systems activated by MR-HIFU from years of preclinical research into a clinical trial together with our partner Thermosome GmbH. The trial is expected to start in the second phase of the project.


For further information see press release of the University Hospital of Cologne.